Prognostic Role of Mismatch Repair Status, Histotype and High-Risk Pathologic Features in Stage II Small Bowel Adenocarcinomas.
Alessandro VanoliFederica GrilloCamilla GueriniGiuseppe NeriGiovanni ArpaCatherine KlersyGabriella NesiPaolo GiuffridaGianluca SampietroSandro ArdizzonePaolo FocianiRoberto FioccaGiovanni LatellaFausto SessaAntonietta D'ErricoDeborah MalviClaudia MescoliMassimo RuggeStefano FerreroGilberto PoggioliFernando RizzelloMaria C MacciomeiDonatella SantiniUmberto VoltaRoberto De GiorgioGiacomo CaioAntonio CalabròCarolina CiacciMaria D'ArmientoAroldo RizzoGaspare SolinaMichele MartinoFrancesco TonelliVincenzo VillanacciRenato CannizzaroVincenzo CanzonieriAda Maria FlorenaLivia BianconeGiovanni MonteleoneRoberto CaronnaAntonio CiardiLuca ElliFlavio CaprioliMaurizio VecchiRenata D'IncàFabiana ZingoneAnna D'OdoricoMarco Vincenzo LentiBarbara OreggiaLuca Reggiani BonettiAntonino Giulio GiannoneAugusto OrlandiValeria BarresiRachele CiccocioppoGiuseppe AmodeoElena BilettaOmbretta LuinettiPaolo PedrazzoliAndrea PietrabissaGino Roberto CorazzaEnrico SolciaMarco PaulliAntonio Di SabatinoPublished in: Annals of surgical oncology (2020)
Mismatch repair protein expression, histologic subtype, association with celiac disease, and, in the mismatch repair proficient subset only, T stage, may help identify patients who may benefit from adjuvant chemotherapy.